RITA Medical to Pre-Pay $6.5 Million in Debt Related to Horizon Merger RITA Medical to Pre-Pay $6.5 Million in Debt Related to Horizon Merger MOUNTAIN VIEW, Calif., Jan 07, 2005 /PRNewswire-FirstCall via COMTEX/ -- RITA Medical Systems, Inc. (Nasdaq: RITA) today announced that its wholly owned

AngioDynamics Reports Fiscal Second Quarter EPS up 50% to $0.09; Conference Call to Begin Today at 4:30 P.M. ET AngioDynamics Reports Fiscal Second Quarter EPS up 50% to $0.09; Conference Call to Begin Today at 4:30 P.M. ET QUEENSBURY, N.Y.--(BUSINESS WIRE)--Dec. 20, 2004--AngioDynamics, Inc.

Peer Reviewed Medical Journal Article Publishes Improved Survival Rates for Metastatic Colorectal Liver Cancer Patients Treated with Radiofrequency Ablation MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--Dec. 16, 2004-- Researchers in Multicenter Trial Conclude RFA Combined with Chemotherapy Improves

AngioDynamics to Hold Fiscal Second Quarter Financial Results Conference Call on Monday, December 20, 2004 QUEENSBURY, N.Y.--(BUSINESS WIRE)--Dec. 14, 2004--AngioDynamics, Inc. (Nasdaq:ANGO) today announced that the company will release its fiscal second quarter results on Monday, December 20, 2004

AngioDynamics Announces the Full USA Release of the EvenMore Chronic Hemodialysis Catheter QUEENSBURY, N.Y., Dec 10, 2004 (BUSINESS WIRE) -- AngioDynamics, Inc. (NASDAQ:ANGO) today announced its release of the EvenMore ™ chronic hemodialysis catheter.

91% Eighteen Month Lung Cancer Survival Statistics Reported in Multicenter Clinical Trial Using RITA Medical Systems Radiofrequency Ablation Products 91% Eighteen Month Lung Cancer Survival Statistics Reported in Multicenter Clinical Trial Using RITA Medical Systems Radiofrequency Ablation Products

Peristaltic Pump Features Automated Operation with Starburst(TM) Xli Enhanced Infusion Radiofrequency Ablation Probe and RITA 1500X Generator

RITA Medical Systems Raises Approximately $12 Million in Private Placement of Common Stock MOUNTAIN VIEW, Calif., Nov. 26 /PRNewswire-FirstCall/ -- RITA Medical Systems, Inc. (Nasdaq: RITA) announced today that it has entered into definitive agreements with a group of institutional and accredited

AngioDynamics Announces Expanding Insurance Coverage of VenaCure Laser Therapy; Anthem, Inc. Covers Laser Ablation Procedure as a Treatment for Varicose Veins QUEENSBURY, N.Y.--(BUSINESS WIRE)--Nov. 24, 2004--AngioDynamics, Inc. (Nasdaq:ANGO) today announced that Anthem, Inc., one of the largest

Breast Cancer Pilot Study Examines New Radiofrequency Ablation-Assisted Lumpectomy Breast Conservation Therapy LITTLE ROCK, Ark. & MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--Nov. 11, 2004-- Study to Determine Whether Procedure Can Reduce Re-Operative Rates and Need for Additional Therapy Following

Senior Medical Device Executive With 23 Years Experience in Executive Management, Sales, Marketing, and Business Development

AngioDynamics Announces Reimbursement Codes and Rates for Its VenaCure Laser Therapy; New Codes Will Simplify Billing and Payment and Promote Acceptance of the Procedure QUEENSBURY, N.Y., Nov 5, 2004 (BUSINESS WIRE) -- AngioDynamics, Inc., (Nasdaq:ANGO) today announced that the Center for Medicare

E-Z-EM Spin-off of AngioDynamics Completed QUEENSBURY, N.Y.--(BUSINESS WIRE)--Nov. 4, 2004--AngioDynamics, Inc. (Nasdaq: ANGO) today announced that the spin-off of AngioDynamics, Inc. from E-Z-EM, Inc. (AMEX: EZM) was completed on October 30, 2004, when E-Z-EM distributed .856377 of a share of

RITA Medical Systems Announces Third Quarter, Nine-Month Results MOUNTAIN VIEW, Calif., Nov. 3 /PRNewswire-FirstCall/ -- RITA Medical Systems, Inc. (Nasdaq: RITA), a medical oncology device company, today announced that sales for the third quarter ended September 30, 2004 were $8.0 million, with a

AngioDynamics Presents New VenaCure Procedure Kit QUEENSBURY, N.Y., Oct 29, 2004 (BUSINESS WIRE) -- AngioDynamics, Inc., (Nasdaq:ANGO) today announced its plans to present the Company's new VenaCure ™ laser vein treatment procedure kit at the American College of Phlebology's 18th Annual

EPS, Gross Margins, Operating Expenses on Target; Total Sales Below Guidance

RITA Medical Systems to Present at Rodman & Renshaw Techvest Healthcare Conference MOUNTAIN VIEW, Calif., Oct 26, 2004 /PRNewswire-FirstCall via COMTEX/ -- RITA Medical Systems, Inc. (Nasdaq: RITA), a medical oncology device company, today announced that President and CEO Joseph M.

RITA Medical Systems Announces Third Quarter, Nine-Month Results Release and Conference Call Date MOUNTAIN VIEW, Calif., Oct. 20 /PRNewswire-FirstCall/ -- RITA Medical Systems, Inc. (Nasdaq: RITA) today announced plans to release its financial results for the third quarter and nine months ended

AngioDynamics Reports Fiscal First Quarter Sales up 23%, Net Earnings Increase Sharply; Conference Call to Begin Today at 4:30 P.M. ET QUEENSBURY, N.Y.--(BUSINESS WIRE)--Oct. 7, 2004--AngioDynamics, Inc. (Nasdaq:ANGO) today announced financial results for the thirteen weeks ended August 28, 2004.

AngioDynamics to Hold Fiscal First Quarter Financial Results Conference Call on Thursday, October 7, 2004 QUEENSBURY, N.Y.--(BUSINESS WIRE)--Oct. 1, 2004--AngioDynamics, Inc. (Nasdaq:ANGO) today announced that the company will release first quarter results on Thursday, October 7, 2004 after market